Zidovudine in Patients with Human Immunodeficiency Virus (HIV) Infection and Kaposi Sarcoma

Abstract

Zidovudine was well tolerated and had antiretroviral activity in patients with early HIV infection and Kaposi sarcoma but it had no significant effect on the extent of Kaposi sarcoma or on immune function.